RenovoRx announces peer-reviewed TAMP publication
RenovoRx said a peer-reviewed publication highlighted the TAMP platform's potential to improve chemotherapeutic delivery for locally advanced pancreatic cancer.
Story updates
12:32:06 PM UTC
SquawkNews
Case Series Reports Tumor Treatment Response, Significant Tumor Marker Reduction, and Changes on Imaging After Treatment with TAMP in Patients with Unresectable LAPCMOUNTAIN VIEW, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) NASDAQ:RNXT, a life-sciences com…